ULTA vs. APLS

In the year-to-date period, ULTA achieves a -11.79% return, which is significantly higher than APLS's -45.19% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Ulta Beauty, Inc. (ULTA) and Apellis Pharmaceuticals, Inc. (APLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ULTA Sharpe Ratio is -0.22, which is higher than the APLS Sharpe Ratio of -1.17. The chart below compares the historical Sharpe Ratios of ULTA and APLS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ULTA nor APLS has paid dividends to shareholders.

The maximum ULTA drawdown since its inception was -87.89%, which is greater than APLS's maximum drawdown of -81.38%. Use the drawdown chart below to compare losses from any high point for ULTA and APLS. For additional features, visit the drawdowns tool.

The current volatility for Ulta Beauty, Inc. (ULTA) is 15.75%, while Apellis Pharmaceuticals, Inc. (APLS) has a volatility of 19.30%. This indicates that ULTA experiences smaller price fluctuations and is considered to be less risky than APLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Ulta Beauty, Inc. and Apellis Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.